Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Indacaterol vs tiotropium in COPD patients classified as GOLD A and B.
Mahler DA, Kerstjens HA, Donohue JF, Buhl R, Lawrence D, Altman P. Mahler DA, et al. Among authors: lawrence d. Respir Med. 2015 Aug;109(8):1031-9. doi: 10.1016/j.rmed.2015.05.012. Epub 2015 May 22. Respir Med. 2015. PMID: 26094050 Free article. Clinical Trial.
Effect of indacaterol on exercise endurance and lung hyperinflation in COPD.
O'Donnell DE, Casaburi R, Vincken W, Puente-Maestu L, Swales J, Lawrence D, Kramer B; INABLE 1 study group. O'Donnell DE, et al. Among authors: lawrence d. Respir Med. 2011 Jul;105(7):1030-6. doi: 10.1016/j.rmed.2011.03.014. Epub 2011 Apr 16. Respir Med. 2011. PMID: 21498063 Free article. Clinical Trial.
Efficacy of indacaterol in the treatment of patients with COPD.
Jones PW, Barnes N, Vogelmeier C, Lawrence D, Kramer B. Jones PW, et al. Among authors: lawrence d. Prim Care Respir J. 2011 Dec;20(4):380-8. doi: 10.4104/pcrj.2011.00066. Prim Care Respir J. 2011. PMID: 21785813 Free PMC article. Review.
Safety of indacaterol in the treatment of patients with COPD.
Donohue JF, Singh D, Kornmann O, Lawrence D, Lassen C, Kramer B. Donohue JF, et al. Among authors: lawrence d. Int J Chron Obstruct Pulmon Dis. 2011;6:477-92. doi: 10.2147/COPD.S23816. Epub 2011 Sep 22. Int J Chron Obstruct Pulmon Dis. 2011. PMID: 22003293 Free PMC article.
Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study.
Decramer ML, Chapman KR, Dahl R, Frith P, Devouassoux G, Fritscher C, Cameron R, Shoaib M, Lawrence D, Young D, McBryan D; INVIGORATE investigators. Decramer ML, et al. Among authors: lawrence d. Lancet Respir Med. 2013 Sep;1(7):524-33. doi: 10.1016/S2213-2600(13)70158-9. Epub 2013 Aug 21. Lancet Respir Med. 2013. PMID: 24461613 Clinical Trial.
2,278 results